ArticleOncoimmunology2016

Anti-TNF-refractory colitis after checkpoint inhibitor therapy: Possible role of CMV-mediated immunopathogenesis.

Katharina Lankes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.